CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Similar documents
CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

KNR Constructions Robust Performance on Execution Ramp-up

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

Punjab National Bank

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

HDFC Bank (HDFCB IN) Continue to perform strong

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

Financial summary. Year

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Punjab National Bank

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

State Bank of India (SBI) Banking BUY RETAIL EQUITY RESEARCH

Buy Rating as per Mid Cap 12months investment period

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

ICICI Bank (ICICIBC IN) Strong improvement in asset quality

Punjab National Bank

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

Punjab National Bank

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Punjab National Bank

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

Union Bank of India NEUTRAL. Performance Highlights CMP. `393 Target Price - 2QFY2011 Result Update Banking. Investment Period -

Union Bank of India (UNIBAN)

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Punjab National Bank

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

State Bank of India (SBI)

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Punjab National Bank

DCB Bank Ltd. 1 P a g e

93,707 77,814 90, NIM

Repco Home Finance REPCO IN

Karur Vysya Bank (KVB) KVB IN; KVB.BO

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Punjab National Bank

Manappuram Finance (MGFL IN) Healthy operating performance

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY Rating as per Largecap 12months investment period

LIC Housing Finance. Source: Company Data; PL Research

Key estimate revision. Financial summary. Year

State Bank of India. Strong operating performance. Source: Company Data; PL Research

Punjab National Bank NEUTRAL. Performance Highlights CMP. `134 Target Price - 2QFY2016 Result Update Banking November 13, Investment Period -

ICICI Bank BUY. Performance Highlights. CMP Target Price `279 `348. 2QFY2016 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank. In line results; loan growth holding nicely. Source: Company Data; PL Research

DCB Bank. Strong performance, valuation comforting

Transcription:

2QFY18 Result Update November 8, 217 Market Cap. (Rs bn) 125 Free Float 37 Shares O/S (mn) 726 PSB Recap A Big Positive; but Earnings to Remain Tepid With lower fresh slippages (lowest in last 8 quarters) and remarkable improvement on asset quality front, (UBI) has positively surprised market in 2QFY18. The Management chosen to strengthen the balance sheet over profitability by increasing Provision Coverage Ratio (PCR) to 49.1% (sans technically w/o loans) and 56.1% (with technically w/o loans) in 2QFY18 compared to 44.3%/51.1% in 1QFY18 and 43.3%/5.4%, respectively in 2QFY17. As a result the provisioning expenses increased by 119.4% YoY and 18.6% QoQ to Rs35.6bn, for which the Bank incurred the first ever net loss of Rs15.3bn in current credit business cycle. However, the Bank s loan book grew by 4.5% QoQ and 9.7% YoY, while its average CASA ratio improved to 34.1% in 2QFY18 compared to 33.9% in 1QFY18. Management Commentary & Guidance The Bank expects loan book, deposit and CASA ratio to grow by 8-1%, 7-8% and 35%, respectively in FY18. It expects slippages ratio and credit cost at ~4.4% and ~3.3% respectively for FY18. The Bank envisages gradual improvement in stressed assets, as most of the recognition has already been done. Its total stressed loan (GNPA + Std. Restructured) stood at 14.1% in total loan book. The Bank s SMA-2 balance substantially declined to 4.4% of loan book (Rs13.6bn) compared to 6.8% of loan book in 1QFY18 and 5.4% in 2QFY17. Though the Bank is yet to receive the RBI s final report on Annual Supervisory Assessment for FY17, the Management does not expect any major divergence. The Management highlighted that the strategy of growing Retail, Agriculture and MSME business is moving in right direction (contribution of RAM stood at 54.1% vs. 53.8% in 4QFY17) led by improvement in retail liability as well as retail loan. Credit cost is expected to increase marginally, as the Bank is looking forward to further improve its PCR to >6% in coming period from the current level of 56.1%. Notably, the Management expects higher upgrade and recovery in current fiscal to support PCR. Outlook & Valuation UBI is one of the most capital-starved public sector banks. Its CET1 stood at 7% in Sep 17, which is barely few bps above minimum regulatory requirement. We expect the Bank can be one of the major beneficiaries of recently announced mega PSB recapitalisation plan, as higher recapitalisation will help the Bank to come out of the capital insuiciency situation and return strongly on the growth path. However, the Bank may continue to witness elevated level of credit cost, which may keep its earnings and return ratios subdued over next 3-6 quarters. Hence, we continue to maintain our recommendation on the stock with an unrevised Target Price of Rs164 based on 1.1x FY19E Adjusted book value. Key Financials E FY19E NII 83,131 89,33 97,184 114,971 PPP 56,426 74,31 75,96 92,729 PAT 13,516 5,552 (9,57) 12,11 EPS (Rs) 19.7 8.1 (12.5) 16.5 P/E (x) 8.4 2.6 (13.3) 1. Adj. BV (Rs) 193.4 168.2 149.7 163.6 P/Adj. BV (x).9 1. 1.1 1. Gross NPA 9. 11.8 12.3 9.3 Net NPA 5.2 6.6 5.8 4.2 Avg. ROA.3.1 (.2).2 Avg. ROE 5.9 2.4 (3.9) 5. Share price 1 mth 3 mth 12 mth Absolute performance 27.8 14.4 24. Relative to Nifty 24.1 11.6 1.2 Shareholding Pattern Jun 17 Sep'17 Promoter 63.4 65.4 Mutual Funds 9.3 7.2 Insurance Companies 11.1 1.5 Foreign Portfolio Investors 5.5 6.1 Others 1.7 1.9 Total 1. 1. 1 Year Stock Price Performance 22 19 16 13 1 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Note: * CMP as on Nov. 7, 217 Research Analyst : Asutosh Kumar Mishra Contact : 22 3321323 Email : asutosh.mishra@relianceada.com 1

Risks to the View Downside Risk: Any major slowdown in economy may adversely impact the Bank s asset quality. Upside Risk: Higher than expected business growth and accelerated resolution of the stressed assets. Exhibit 1: Income Statement Analysis 2Q FY18 2Q FY17 % yoy / bps 1Q FY18 % qoq / bps 1H FY18 1H FY17 % yoy / bps Interest on Advance 57,543 58,171 (1.1) 57,377.3 114,919 115,86 (.8) YoA - Calculated 8.1 8.9 (83) 8.1 (4) 8.1 8.9 (8) Income on Investment 21,949 21,43 4.3 21,477 2.2 43,425 39,88 9.1 Interest on Balances 2,588 2,183 18.5 2,55 1.5 5,138 4,163 23.4 Others Interests 145 685 (78.8) 127 14.4 272 1,71 (74.6) Interest Earned 82,224 82,81.2 81,53.9 163,754 16,848 1.8 Interest Expended 59,17 59,37 (.5) 59,14 (.1) 118,121 117,51.9 CoF - Calculated 5.2 5.8 (58) 5.4 (15) 5.2 5.7 (5) Net Interest Income 23,27 22,774 1.9 22,426 3.5 45,633 43,797 4.2 NIM - Calculated 2.2 2.4 (2) 2.2 2.3 (15) NIM - Reported 2.3 (22) 2 NA NA NA NII as % of Oper. Income 65.6 66.7 (16) 61.3 427 63.4 66.8 (335) Core Fee Income 5,49 4,98 1.2 6,6 (9.4) 11,55 9,55 2.9 Fee Inc. as % of OI 15.5 14.6 94 16.6 (15) 16.1 14.6 1 Non Core Fee Income 6,683 6,414 4.2 8,87 (17.4) 14,77 12,243 2.6 Non core fee Inc. as % of OI 18.9 18.8 12 2 (322) 2.5 18.7 1 Total Other Income 12,173 11,394 6.8 14,147 (13.9) 26,32 21,793 2.8 Other Inc. as % of OI 34.4 33.3 16 38.7 (427) 36.6 33.2 335 Operating Income (OI) 35,381 34,169 3.5 36,573 (3.3) 71,953 65,59 9.7 Core Operating Income 28,697 27,754 3.4 28,486.7 57,183 53,347 7.2 Employees Expenses 8,58 8,736 (7.8) 8,213 (1.9) 16,271 17,326 (6.1) Employees Expn. as % of OI 22.8 25.6 (279) 22.5 32 22.6 26.4 (38) Other Operating Expenses 7,933 7,236 9.6 7,794 1.8 15,727 13,817 13.8 Other Opert Exp. as % of OI 22.4 21.2 125 21.3 111 21.9 21.1 79 Total Operating Expenses 15,991 15,972.1 16,7 (.1) 31,998 31,143 2.7 Cost to income Ratio 45.2 46.7 (155) 43.8 143 44.5 47.5 (31) Operating Profit (OP) 19,39 18,197 6.6 2,566 (5.7) 39,956 34,448 16. Provisions and Conting. 35,547 16,23 119.4 17,37 18.6 52,584 29,733 76.9 Pro Burden as % of OP 183.3 89. 9,429 82.8 1,49 131.6 86.3 4,529 Profit Before Tax (16,157) 1,994 (91.2) 3,529 (557.9) (12,628) 4,715 (367.8) Tax Expenses (85) 227 (473.7) 2,363 (136.) 1,513 1,285 17.7 Eective Tax Rate 5.3 11.4 (614) 67. (6,17) (1) 27.3 (3,924) Net Profit (15,37) 1,767 (966.4) 1,166 (1,413.) (14,141) 3,43 (512.3) EPS (21.9) 2.6 (951.1) 1.7 (1,386.6) (2.2) 5. (54.3) 2

Exhibit 2: NIM witnessed improvement in 2QFY18 led by lower cost of funds Exhibit 3: NII growth improved sequentially led by higher share of RAM segments 2.5 2.4 2.3 2.2 1.9 1.8 2.4 2.3 2.3 2.3 2.3 2.3 2.2 26, 24, 22, 2, 18, 2.2 2.2 1.9 2.3 2.2 1.9 1.8 1.7 NII (LHS) NII as % of Avg. Assets Exhibit 4: Other income growth remained subdued led by lower treasury profit 16, 12, 8, 4, 26.9 31.3 3.9 32.3 33.1 33.3 38.5 37.7 38.7 34.4 5. 4. 3. 2. 1.. Exhibit 5: Operating expenses remained subdued as UBI focused towards contorting other opex 18, 16,5 15, 13,5 12, 48.9 51.3 53.8 54.2 48.3 46.7 46.7 44.3 43.8 45.2 6 45 3 15 Other Income OI as % of Operating Income Operating Expenses C/I Ratio Exhibit 6: The Bank frontloaded provision on loans referred to NCLT, which led to sharp surge in PCR Exhibit 7: Higher provisioning and lower operating profit negatively impacted UBI s bottom-line 4, 3, 2, 1, 43.2 29. 92.8 111. 83.3 89. 9.2 114.5 82.8 183.3 2 16 12 8 4 1 5 (5) (1) (15) -21.9 77.2-74. -78.3-67.9-73.2 32.4 12.6-29.9-966.4 4.. (4.) (8.) (1,2.) Provision Expenses Provision as % of OP PAT (LHS) Growth YoY (RHS) 3

Exhibit 8: Balance Sheet Analysis (Rs bn) 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Net Worth 234.4 235.8 234.4 235.3 226.1 (3.9) (3.5) (3.6) Deposit 3,615 3,798 3,784 3,758 3,86 2.7 6.8 Savings Deposits 96 1,11 1,41 1,48 1,75 2.6 3.3 18.7 Current Deposits 235 296 262 287 221 (23.) (15.9) (5.9) CASA Deposit 1,14 1,397 1,33 1,334 1,296 (2.9) (.6) 13.7 Term Deposit 2,474 2,41 2,481 2,424 2,564 5.8 3.4 3.6 Investments 1,19 1,352 1,121 1,215 1,284 5.7 14.5 7.9 Advances 2,652 2,627 2,865 2,784 2,99 4.5 1.5 9.7 Total Business 7,457 7,777 7,77 7,757 8,53 3.8 3.6 8. Avg Int. Earning Assets 3,961 4,252 4,26 4,355 4,463 2.5 6.1 12.7 Risk Weighted Assets 2,813 2,819 2,912 2,868 2,93 1.2 (.3) 3.2 CAR 11.2 11.4 11.8 1 11.2 (79) (57) 3 Tier I Capital 8.6 8.5 9. 9.2 8.5 (74) (52) (6) Exhibit 9: Loan book growth was driven by RAM and domestic corporate segments Exhibit 1: Deposit growth was led by retail term and saving deposits (Rs bn) (Rs bn) 3 2 1 (1) (2) (3.) (.8) 3. 5.4 (3.9) 3.2 (1.) 9.1 (2.8) 4.5 12 8 4 (4) (8) 3 2 1 3.3 1. (1.) 4.7 (1.2) 6.7 5.1 (.4) (.7) 2.7 9. 6. 3.. (1) (3.) Incremental loan disbursement (LHS) Adv. Gr. qoq Incremental Deposit Mobilization (LHS) Deposit Gr. qoq (RHS) Exhibit 11: Loan Book Analysis 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Agriculture 411,59 47,23 441,24 44,92 429,9 (2.7) (2.8) 4.3 MSME 582,68 57,97 619,13 66,76 622,55 2.6.6 6.8 Large Corporate & Other 1,18,61 999,45 1,16,36 1,17,76 1,8,91 6.1 (2.3) 6.1 Retail Advances 374,92 376,23 43,8 423,57 447,39 5.6 1.8 19.3 Overseas 264,8 272,71 294,46 294,92 329,38 11.7 11.9 24.4 Exhibit 12: Loan Book Analysis (% Break Up) 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Agriculture 15.5 15.5 15.4 15.8 14.8 (19) (65) (77) MSME 2 21.7 21.6 21.8 21.4 (39) (21) (57) Large Corporate & Other 38.4 38.1 38.6 36.6 37.1 58 (147) (125) Retail Advances 14.1 14.3 14.1 15.2 15.4 17 129 125 Overseas 1. 1.4 1.3 1.6 11.3 73 15 134 4

Exhibit 13: Management is targeting average CASA ratio of 34-35% by Mar 18 (Rs bn) 1,6 1,2 8 4 28.3 28.6 3.6 32.3 31.5 31.5 36.8 34.4 35.5 33.6 4. 3. 2. 1.. Exhibit 14: PSB recap plan is expected to provide much-needed fillip to UBI on capital front 15 12 9 6 3 1.1 7.2 1.3 7.4 1.3 7.7 1.6 8.1 1.8 8.4 11.2 8.6 11.4 8.5 11.8 9. 1 9.2 11.2 8.5 CASA Deposits (LHS) CASA Ratio (RHS) Total CAR Tier I 5

Exhibit 15: Asset Quality Analysis 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Gross Non Performing Assets 298,621 324,27 337,119 372,863 382,858 2.7 13.6 28.2 Fresh Slippages 33,96 32,94 29,51 44,53 26,86 (39.7) (9.) (2.9) Net Non Performing Assets 169,479 182,456 188,321 27,85 194,794 (6.3) 3.4 14.9 GNP Ratio 1.7 11.7 11.2 12.6 12.4 (28) 118 162 NNP Ratio 6.4 7. 6.6 7.5 6.7 (77) 13 31 NPA Coverage Ratio 43.25 43.69 44.14 44.26 49.12 487 498 588 Restructured Gross Loans 56,36 55,23 56,96 38,57 52,7 36.6 (7.5) (6.5) Restr. Loan as % of Adv. 1.4 1.8 43 (18) (31) Exhibit 16: Slippages declined sequentially during the quarter under review Exhibit 17: Lower fresh slippages along with higher write-o helped the Bank to contain GNE growth 1 1. 8. 6. 4. 2.4 3.1 5.5 9.7 5.4 5.3 5. 4.5 6.2 3.9 6, 45, 3, 15, 8.5 9.9 19. 3.7 12.9 9.5 8.5 4. 1.6 2.7 36. 27. 18. 9... Incremental Gross NPA (LHS) Gross NPA Gr. qoq (RHS) Exhibit 18: PCR improved due to relatively higher provisioning during the quarter Exhibit 19: Lower GNP formation and higher provisioning expenses led to moderation in net NPA formation 5 48 46 44 42 46. 46.4 44.2 4 4 43.2 43.7 44.1 44.3 49.1 25, 2, 15, 1, 5, 3.1 3.4 4.1 5.2 6.2 6.4 7. 6.6 7.5 6.7 8. 6. 4.. 4 38 Net NPA (LHS) Net NPA Ratio (RHS) 6

Profit & Loss Statement (Y/E March, Rs mn) E FY19E Interest Earned 321,988 326,6 332,647 37,579 Interest Expenditure 238,857 237,566 235,463 255,68 Net Interest Income 83,131 89,33 97,184 114,971 Fee Income 4,98 4,687 6,826 8,614 Non Fee Income 32,22 44,959 41,339 46,983 Other Income 36,317 49,646 48,166 55,597 Net Operating Income 119,448 138,679 145,35 17,568 Core Operating Income 87,229 93,721 14,11 123,585 Employee Expenses 36,993 34,342 37,776 43,65 Other Expenses 26,29 3,36 31,613 34,775 Operating Expenses 63,22 64,378 69,39 77,84 Operating Profit 56,426 74,31 75,96 92,729 Provisions and Contingencies 38,772 7,786 85,19 74,935 Profit Before Tax 17,654 3,515 (9,148) 17,794 Taxes 4,138 (2,38) (91) 5,783 Profit After Tax 13,516 5,552 (9,57) 12,11 Balance Sheet (Y/E March, Rs mn) E FY19E Capital & Liabilities Capital 6,874 6,874 7,264 7,264 Reserves Total 222,38 227,478 222,673 231,75 Net Worth 228,912 234,352 229,937 238,97 Deposits 3,427,2 3,783,916 4,15,549 4,557,159 Current deposits 297,431 262,363 338,78 364,573 Saving deposits 811,326 1,4,724 1,98,234 1,253,219 Term Deposits 2,318,442 2,48,829 2,668,67 2,939,368 Borrowings 39,574 412,259 67,759 728,359 Other Liabilities & Provisions 81,273 91,18 83,516 87,291 Total Liabilities 4,46,959 4,527,44 5,26,761 5,611,778 Assets Cash & Cash Equivalents 292,762 328,225 364,983 47,526 Investments 892,83 1,121,49 1,228,427 1,345,751 Advances 2,673,54 2,864,666 3,194,12 3,593,365 Fixed Assets 39,399 38,944 4,339 41,263 Other Assets 149,175 173,72 198,99 223,872 Total Assets 4,46,959 4,527,44 5,26,761 5,611,778 7

Per Share Data and Valuation Y/E March FY16 FY17E FY18E FY19E No. of Shares (mn) 687.4 687.4 726.4 726.4 Earnings Per Share (Rs) 19.7 8.1 (12.5) 16.5 Book Value / Share (Rs) 295.4 35.2 283.8 297.7 ABV/Share (Rs) 193.4 168.2 149.7 163.6 Dividend Per Share (Rs) 8.3 8.4-2.2 Price/ Earnings (x) 8.4 2.6 (13.3) 1. Price/ BV (x).6.5.6.6 Price/Adjusted BV (x).9 1. 1.1 1. Key Assumptions Loan Growth 4.6 7.1 11.5 12.5 Deposit Growth 8.2 1.4 8.5 11. RWA Growth 8.1 6.4 1 1 Slippages Ratio 5.1 5. 3.8 Cost of Fund 6.2 5.7 5. 4.9 Yield on Fund 8.9 8.3 7.6 7.6 NIM 2.3 2.3 2.2 2.3 Other Income Growth 3.1 36.7 (3.) 15.4 Cost to Income Ratio 52.8 46.4 47.7 45.6 Average Credit Cost 1.5 2.6 3. 2.3 Eective Tax Rate 23.4 (58.) 1. 32.5 Growth Rate Net interest Income (1.5) 7.1 9.2 18.3 Other Income 3.1 36.7 (3.) 15.4 Operating Profit (3.1) 31.7 2.2 2 Provisions Expense 27.5 82.6 2.2 (1) PAT (24.1) (58.9) (263.1) (232.6) Risk Weighted Assets 8.1 6.4 1 1 Yields / Margins Cost of Funds (CoF) 6.2 5.7 5. 4.9 Yield on Advance 9. 8.3 7.4 7.5 Yield on funds 8.9 8.3 7.6 7.6 Net Interest Margin (NIM) 2.3 2.3 2.2 2.3 Balance Sheet Ratio Credit / Deposit Ratio 78. 75.7 77.8 78.9 Incremental C/D Ratio 45.3 53.6 12.4 88.4 Investment-Deposit Ratio 26. 29.6 29.9 29.5 CASA Ratio 32.4 34.4 35. 35.5 8

Asset Quality Gross NPA/Gross Advances 9. 11.8 12.3 9.3 Net NPA/Net Advances 5.2 6.6 5.8 4.2 Provisioning Burden as % of PPP 68.7 95.3 11 8.8 Provisioning Coverage Ratio 4 44.1 53.1 55.1 Slippage ratio 5.1 5. 3.8 Provis. Exp. to Avg. Advance 1.5 2.6 2.8 2.2 RoA Tree Analysis NII / Avg. Assets 2.2 Core Fee / Avg. Assets.1.1.1.2 Core Rev. / Avg. Assets 2.2 2.2 2.2 2.3 Ope. Exp. / Avg. Assets 1.6 1.5 1.5 1.5 Cost to Income 52.8 46.4 47.7 45.6 Emp. cost / Avg. Assets.9.8.8.8 Oprt. Exp. / Avg. Assets.7.7.7.7 Core OP/ Avg. Assets.6.7.7.9 Trading & Ot/ Avg. Assets.8 1..9.9 OP/ Avg. Assets 1.4 1.7 1.6 1.7 Provisions / Avg. Assets 1. 1.7 1.8 1.4 NPA prov. / Avg. Assets 1.2 1.4 1.6 1.2 PBT / Avg. Assets.4.1 (.2).3 Tax / Avg. Assets.1 (.) (.).1 Eective Tax Rate 23.4 (58.) 1. 32.5 RoA.3.1 (.2).2 Leverage (x) 17.7 19.3 21.9 23.5 RoE 5.9 2.4 (3.9) 5. Capital Adequacy Ratio Total CAR 1.6 11.8 1.1 9.1 Tier 1 8.1 9. 7.7 6.9 9

Rating Guides Rating Expected absolute returns over 12 months BUY >1% -5% to 1% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 214 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U6599MH25PLC15452. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 11234839, Depository Participants: CDSL IN-DP-257-216 IN-DP-NSDL-363-213, Research Analyst: INH2384); AMFI ARN No.29889. 1